Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 1, 2014, Pages

  Abu Saleh, Niroz ^a   Awad, Hoda ^a   Khamaisi, Mogher ^a   Armaly, Zaher ^b   Karram, Tony ^c   Heyman, Samuel N ^d   Kaballa, Aviva ^a   Ichimura, Takaharu ^e   Holman, James ^e   Abassi, Zaid ^a,f  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Nazareth Hospital   (Israel)

^c Department of Vascular Surgery ^*  (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Research Unit   (Israel)

Author keywords

Acute kidney injury; Diabetes mellitus; Oxidative stress; Rasagiline

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; EOSIN; GLUCOSE; HEMATOXYLIN; RASAGILINE; SODIUM; STREPTOZOCIN; TEMPOL;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ISCHEMIC ACUTE KIDNEY FAILURE; ISOMER; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; RENAL PROTECTION; REPERFUSION INJURY; SODIUM EXCRETION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; URINE FLOW RATE; WEIGHT REDUCTION;

EID: 84891526732     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00379.2013     Document Type: Article

References (34)

1. Abassi ZA, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H, Blank A, Bar-Am O, Amit T, Schaper J, Youdim M, Binah O. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail 4: 463-473, 2011.
2. Abu-Saleh N, Ovcharenko E, Awad H, Goltsman I, Khamaisi M, Hoffman A, Heyman SN, Winaver J, Abassi Z. Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sci 91: 669-675, 2012.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
4. Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36: 557-562, 2003.
5. Chatterjee A, Black SM, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol 49: 134-140, 2008.
6. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000.
7. Ertracht O, Liani E, Bachner-Hinenzon N, Bar-Am O, Frolov L, Ovcharenko E, Awad H, Blum S, Barac Y, Amit T, Adam D, Youdim M, Binah O. The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion. Br J Pharmacol 163: 755-769, 2011.
8. Fuhr J, Kaczmarczyk J, Kruttgen CD. [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics]. Klin Wochenschr 33: 729-730, 1955.
9. Fujii T, Takaoka M, Ohkita M, Matsumura Y. Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction. Biol Pharm Bull 28: 641-645, 2005.
10. Goligorsky MS. Whispers and shouts in the pathogenesis of acute renal ischaemia. Nephrol Dial Transplant 20: 261-266, 2005.
11. Goor Y, Peer G, Iaina A, Blum M, Wollman Y, Chernihovsky T, Silverberg D, Cabili S. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia 39: 1036-1040, 1996.
12. Guilgen G, Werneck ML, de Noronha L, Martins AP, Varela AM, Nakao LS, Pecoits-Filho R. Increased calcification and protein nitration in arteries of chronic kidney disease patients. Blood Purif 32: 296-302, 2011.
13. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999.
14. Kiris I, Kapan S, Kilbas A, Yilmaz N, Altuntas I, Karahan N, Okutan H. The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. J Surg Res 149: 206-213, 2008.
15. Kleiner Y, Bar-Am O, Amit T, Berdichevski A, Liani E, Maor G, Reiter I, Youdim MB, Binah O. TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity. J Cardiovasc Pharmacol 52: 268-277, 2008.
16. Lameire NH, Vanholder R. Pathophysiology of ischaemic acute renal failure. Best Pract Res Clin Anaesthesiol 18: 21-36, 2004.
17. Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal 10: 1631-1674, 2008.
18. Lee E, Ryu GR, Ko SH, Ahn YB, Yoon KH, Ha H, Song KH. Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes. Biochem Biophys Res Commun 414: 397-402, 2011.
19. Lejeune D, Hasanuzzaman M, Pitcock A, Francis J, Sehgal I. The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells. Mol Cancer 5: 21, 2006.
20. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 52: 985-991, 1997.
21. Melin J, Hellberg O, Fellstrom B. Hyperglycaemia and renal ischaemiareperfusion injury. Nephrol Dial Transplant 18: 460-462, 2003.
22. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
23. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289: H2144-H2152, 2005.
24. Nilakantan V, Hilton G, Maenpaa C, Van Why SK, Pieper GM, Johnson CP, Shames BD. Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury. Mol Cell Biochem 304: 1-11, 2007.
25. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-F957, 2001.
26. Rosenberger C, Khamaisi M, Goldfarb M, Shina A, Shilo V, Zilbertrest F, Rosen S, Heyman SN. Acute kidney injury in the diabetic rat: studies in the isolated perfused and intact kidney. Am J Nephrol 28: 831-839, 2008.
27. Schlichting CL, Schareck WD, Weis M. Renal ischemia-reperfusion injury: new implications of dendritic cell-endothelial cell interactions. Transplant Proc 38: 670-673, 2006.
28. Shi H, Patschan D, Epstein T, Goligorsky MS, Winaver J. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am J Physiol Renal Physiol 293: F1512-F1517, 2007.
29. Vander Jagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 34: 265-270, 2001.
30. Villanueva S, Cespedes C, Gonzalez AA, Vio CP, Velarde V. Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney. Am J Physiol Renal Physiol 292: F1364-F1371, 2007.
31. Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 24: 3263-3265, 2009.
32. Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 23: 13-21, 2012.
33. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20: 672-679, 2009.
34. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of Tempol and other nitroxides. Pharmacol Rev 60: 418-469, 2008.